- ISIN DE000A37FT41
- Country Deutschland
Latest Reports
News Functions
Additional Functions
14 March 2024
Epigenomics AG
Jahresabschluss 2023
10 August 2023
Epigenomics AG
Halbjahresfinanzbericht 2023
31 May 2023
Epigenomics AG
Q1 statement / Q1 financial report 2023
28 April 2023
Epigenomics AG
Jahresfinanzbericht 2022
Epigenomics AG
Annual financial report 2022
9 November 2022
Epigenomics AG
Q3 statement / Q3 financial report 2022
10 August 2022
Epigenomics AG
Half-yearly financial report 2022
11 May 2022
Epigenomics AG
Q1 statement / Q1 financial report 2022
31 March 2022
Epigenomics AG
Annual financial report 2021
Epigenomics AG
Jahresfinanzbericht 2021
10 November 2021
Epigenomics AG
Q3 statement / Q3 financial report 2021
11 August 2021
Epigenomics AG
Half-yearly financial report 2021
12 May 2021
Epigenomics AG
Q1 statement / Q1 financial report 2021
7 April 2021
Epigenomics AG
Annual financial report 2020
Epigenomics AG
Jahresfinanzbericht 2020
12 November 2020
Epigenomics AG
Q3 statement / Q3 financial report 2020
13 August 2020
Epigenomics AG
Half-yearly financial report 2020
7 May 2020
Epigenomics AG
Q1 statement / Q1 financial report 2020
29 April 2020
Epigenomics AG
Annual financial report 2019
Latest News
News Functions
Additional Functions
29 July 2024
Epigenomics AG
22 July 2024
Epigenomics AG
Epigenomics AG: Vorläufiges Halbjahresergebnis zum 30. Juni 2024
18 July 2024
Epigenomics AG
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
30 April 2024
Epigenomics AG
Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024
10 April 2024
Epigenomics AG
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
14 March 2024
Epigenomics AG
Epigenomics AG publishes financial results for fiscal year 2023